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Summary Introduction
The M235T polymorphism of the angiotensinogen gene The angiotensinogen gene (AGT) has been implicated in
(AGT) has been associated with essential and pregnancy- essential hypertension through both genetic linkage and
induced hypertension. Generation of haplotypes can help allelic association. Positive linkage was established ini-
to resolve whether the T235 allele itself predisposes to the tially in both Utah and French Caucasians (Jeunemaitre
development of hypertension or acts as a marker of an et al. 1992) and was conﬁrmed later in two others sets of
unknown causal molecular variant. We identiﬁed 10 dial- Caucasian (Caulﬁeld et al. 1994) and African-Carribean
lelic polymorphisms at the AGT locus and genotyped both (Caulﬁeld et al. 1995) hypertensive families. Apart from
a series of 477 probands of hypertensive families and 364 rare mutations that potentially affect the kinetics of an-
controls, all French Caucasians, as well as a series of 92 giotensinogen II generation (Inoue et al. 1995) or the
hypertensives and 122 controls from Japan. Despite a large secondary structure and secretion of the protein (Gi-
ethnic difference in gene frequency, a signiﬁcant associa- menez-Roqueplo et al. 1996), the M235T polymor-
tion of T235with hypertension was observed both in Cau- phism encoding a threonine instead of a methionine at
casians (.46 vs. .38, P Å .004) and in Japanese (.91 vs. residue 235 of the mature angiotensinogen protein was
.76, P Å .002). In both groups, the GrA substitution signiﬁcantly more common in hypertensive subjects than
located at position06 upstream of the initial transcription in normotensive controls, in both Utah and French Cau-
site occurred at the same frequency and in complete link- casians (Jeunemaitre et al. 1992). This association was
age disequilibrium with the T235 allele. No other poly- conﬁrmed in unselected French hypertensives participat-
morphism was found to be consistently associated with ing in a clinical trial (Jeunemaitre et al. 1993) and in
hypertension. Five informative haplotypes subdividing the hypertensives with age at onset at õ50 years who were
T235 allele were generated. Whereas two of them were selected in Germany (Schmidt et al. 1995). Two other
associated with hypertension in Caucasians, none of these studies found an association with the T174M polymor-
two haplotypes (H3 and H4) reached statistical signiﬁ- phism, which is in complete linkage disequilibrium with
cance in Japanese. The analysis of the AGT-GT repeat M235T. They indicated that this association could be
revealed marked linkage disequilibriums between each of restricted either to males (Hegele et al. 1994) or to non-
the diallelic polymorphisms and some (GT)n alleles, with overweight hypertensives (Tiret et al. 1995). Despite a
similar patterns in the two populations. The strong dis- strong ethnic difference in allele frequency, the associa-
equilibrium between M235 and (GT)16 explained the in- tion with M235T also held in the Japanese population
creased frequency of that particular allele in French con- (Hata et al. 1994; Kamitani et al. 1994; Iwai et al. 1995;
trols compared with hypertensives (.42 vs. .36, P õ .01). Nishiuma et al. 1995). In addition, M235T was also
The haplotype combining the M235T andG-6A polymor- signiﬁcantly associated with preeclampsia in Caucasians
phisms appears as the ancestral allele of the human AGT as well as in Japanese (Ward et al. 1993), a ﬁnding
gene and as the one associated with hypertension. substantiated by a later report of signiﬁcant linkage be-
tween AGT and preeclampsia in pedigrees from Scot-
land and Iceland (Arngrimsson et al. 1993). Finally, new
reports suggest that M235T could also represent a ge-Received September 10, 1996; accepted for publication March 17,
netic risk factor for coronary-artery disease in Cauca-1997.
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First, presence of the T235 allele has been associated ﬁnding that a polymorphism occurring six residues up-
stream from the initiation site of transcription, G-6A,with a 10%–20% increase in plasma angiotensinogen
(Jeunemaitre et al. 1992, 1993; Bloem et al. 1995). A was in complete linkage disequilibrium with M235T
and that the haplotype combining both polymorphismspositive relation between plasma angiotensinogen and
blood pressure (BP) is supported by physiological was the one associated with hypertension.
(Gould and Green 1971) and pharmacological (Gardes
et al. 1982; Me´nard et al. 1991) considerations and Subjects and Methods
by the reported differences in plasma angiotensinogen
A. Study Subjectsconcentration that are observed between hypertensives
and normotensives (Fasola et al. 1968; Walker et al. The grandparents of the Utah families included in the
CEPH database were used as controls for the frequency1978). More-recent results, obtained by the inactivation
or duplication of the AGT gene in transgenic mice, of the AGT diallelic polymorphisms and to deﬁne the
corresponding haplotypes. French hypertensive patientsshowed a relationship between AGT gene expression,
plasma angiotensinogen, and BP (Kim et al. 1995). were selected from the HYPERGENE data set of hyper-
tensive families recruited in the Broussais HypertensionWhether the T235 allele directly accounts for a physi-
ological effect or acts as a marker for a causative muta- Clinic in Paris (Charru et al. 1994). Only the 477 pro-
bands (age 49.4 { 8.4 years; 48% men) who satisﬁedtion is as yet unresolved. Three possible interpretations
can account for the observed associations: (1) T235 the following main criteria were considered: Caucasian
origin, hypertension established on the basis of diastoliccould represent the main functional mutation within the
angiotensinogen gene, which predisposes to the develop- BP §95 mmHg and/or the presence of an antihyperten-
sive treatment (mean BP 158.9 { 22.6/98.8 { 13.3ment of essential hypertension; (2) it could serve as a
marker for yet unknown molecular variant(s), directly mmHg; 73% on treatment), onset of hypertension at
õ55 years of age (40.3 { 10.8 years), and body-massmediating predisposition; or (3) both T235 and the other
variants could be causally implicated. Genetic methods indexõ27 kg/m2 (25.4{ 3.8). The absence of secondary
hypertension was established by an extensive inpatienthave the potential to provide a powerful test for the
presence or absence of other causal variants. If T235 workup when the latter was clinically indicated. The
absence of diabetes mellitus (mean blood glucose 5.4acts as a marker, it is logical to assume that only a subset
of the genes carrying T235 also harbor the functional { 0.7 mmol/liter) was assessed by the presence of the
following three criteria: (1) the absence of personal diag-mutation(s). In this case, other polymorphisms at the
AGT locus can be used to subdivide T235 alleles into a nosis of diabetes mellitus, (2) the absence of antidiabetic
drug treatment, and (3) a fasting blood-glucose levelseries of distinct haplotypes. These haplotypes should
exhibit a variable degree of association with the causal õ6.5 mmol/liter. Also, patients were not eligible when
other factors that could affect BP—for example, renalmutation(s) and, thus, with hypertension. This situation
has been observed in other genetic situations, such as insufﬁciency (mean plasma creatinine 85.8 { 22.4
mmol/liter), excessive alcohol consumption, and estro-hemoglobinopathies (Weatherall 1995). For the AGT
gene, this hypothesis was suggested by two studies gen use—were present.
Among these 477 probands of hypertensive families,(Caulﬁeld et al. 1994, 1995) that found that different
alleles of the AGT microsatellite actually could bear the 75 probands already had been studied in our previous
analysis (Jeunemaitre et al. 1992). The clinical and bio-susceptibility to hypertension.
To address this question, we have identiﬁed a series of logical characteristics of these 75 probands were not
statistically different from those of the other 402 pro-10 diallelic AGT polymorphisms and have characterized
their haplotype distribution in a large series of hyperten- bands. They were not excluded from this analysis, in
order to keep the maximal power of the haplotype anal-sive cases and normotensive controls of Caucasian and
Japanese origin. We also genotyped the microsatellite of ysis.
French normotensive patients were selected by the In-the AGT locus (Kotelevtsev et al. 1991), thus enabling
an analysis of the disequilibrium patterns between the stitut Re´gional pour la Sante´ (IRSA) during an annual
medical visit for preventive medicine. All of the 364two types of polymorphisms. Partition of the T235 allele
with diallelic markers did not unambiguously pinpoint individuals analyzed were Caucasians and were re-
cruited in two main centers of the regions Centre anda subset of T235 haplotypes responsible for the associa-
tion with hypertension. Likewise, the only signiﬁcant Picardie, which are located Ç200 km south and north
of Paris, respectively. This control group was differentdifferences observed, in the distribution of GT alleles,
between hypertensive and normotensive subjects of Cau- from that analyzed in our previous study (Jeunemaitre
et al. 1992). Normotensive individuals were selected tocasians or origin were attributable to the strong linkage
disequilibrium existing between M235 and the (GT)16 match the distributions of age (46.1{ 7.6 years), gender
(44% men), and body-mass index (23.6 { 2.2 kg/m2)repeat allele. The main outcome of this search was the
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observed in the hypertensive subjects. All had sitting 0800 to nucleotide 01), the ﬁve exons, and the entire
untranslated region of the gene.systolic and diastolic BP õ140 and õ90 mmHg (mean
2. Genotyping.—The frequency of each variant wasBP 113.8 { 9.4/71.4 { 6.5 mmHg), respectively, with-
established in cases and controls by allele-speciﬁc oligo-out any history of hypertension or antihypertensive
nucleotide hybridization using the methodology de-treatment, diabetes mellitus (mean blood glucose 5.02
scribed elsewhere (Jeunemaitre et al. 1992) and the{ 0.5 mmol/liter), renal insufﬁciency (mean plasma cre-
primers indicated in table 2. The G-6A variant couldatinine 71.6 { 12.2 mmol/liter), or cardiovascular dis-
not be resolved by this technique without ambiguity,ease and without family history (in parents and siblings)
probably because of the high GC content of that se-of hypertension.
quence. We used the mutagenically separated PCR tech-Japanese hypertensives and controls have been de-
nique, in which both normal and mutant alleles arescribed elsewhere (Hata et al. 1994). Patients had es-
ampliﬁed in the same tube, using different length allele-tablished hypertension (systolic BP ú160 mmHg and/
speciﬁc primers (Rust et al. 1993). The following prim-or diastolic BP ú90 mmHg), in the absence of any
ers were designed with one forward primer and twosecondary cause, diabetes, or renal disease. All patients
reverse primers in which additional deliberate differ-and controls were ascertained at Yamanishi University
ences (underlined) were introduced to correspond to theHospital.
molecular variant and to reduce cross-reactions between
the two alleles: FP-6, 5-GTGTCGCTTCTGGCATCTGB. Identiﬁcation of Polymorphisms
TCCTTCTGG-3; RP-6A, 5-TACCCAGAACAA-
1. Search for new diallelic polymorphisms.—Our ini- CGGCAGCTTCTTCCACT-3; and RP-6G, 5CCG-
tial search for polymorphisms (Jeunemaitre et al. 1992), GTTACCTTCTGCTGTACAGCCCAGAACAACG-
relying on conformational variation in electrophoresis GCAGCTTCTTCCATC-3.
under nondenaturing conditions (Orita et al. 1989), PCR reactions were conducted in a 25-ml reaction
spanned all coding segments of exons and splice junc- volume containing 2.5 ml of 10 1 PCR buffer (500 mM
tions. In addition to the M235T and T174M missense KCl, 100 mM Tris HCl pH 8.3, and 0.01% gelatine),
mutations, four other polymorphisms, at positions 1.5 mM MgCl2, 10 mM each of the four dNTPs, 100532, 020, 018, and 06 upstream of the transcription pmol each of the three primers, and 0.5 units Taq poly-
start site, and a polymorphism in intron 3, at position merase. The ﬁrst denaturation step (94C for 5 min) was013 relative to the beginning of exon 4, had been de- followed by 35 cycles, each of 94C for 45 s, 62C for
tected. With the same methodology, this search was ex- 45 s, and 72C for 45 s, and by a ﬁnal extension at 72C
tended to nucleotide 01221 upstream of the gene, in a for 7 min. The ampliﬁcation reaction yields a 187-bp
panel of 96 French hypertensive subjects. and a 207-bp product for the A-6 and G-6 alleles, respec-
Each sample was electrophoresed under at least two tively, which were resolved on a 2% agarose gel.
conditions: (1) a 0.5 1 Hydrolink TM MDETM (AT Bio- 3. Analysis of the GT alleles at the AGT locus.—The
chem) prepared in 0.6 1 TBE (1 1 TBE Å 90 mM Tris- AGT genotypes of the highly informative dinucleotide
borate [pH 7.8], 2 mMEDTA), run at room temperature repeat located in the 3-ﬂanking region of the AGT gene
at 400 V for 14–20 h; and (2) a 5% polyacrylamide gel were established as described elsewhere (Jeunemaitre et
(49:1 polyacrylamide:methylene-bis acrylamide) pre- al. 1992). To avoid any ambiguity in comparisons with
pared in 0.5 1 TBE, run at /4C at 15 W constant allelic frequencies obtained in other studies, we classiﬁed
power for 3–4 h. Direct sequencing of electrophoretic the alleles according to their number of GT repeats and
variants was performed as described elsewhere (Jeune- to provide in the ﬁgures a correspondence with the num-
maitre et al. 1992). bering scheme used initially by Kotelevtsev et al. (1991).
Several segments of the 3 region of the human AGT
C. Statistical Analysisgene have been shown to contain sequences involved in
the cell type-dependent activation of the gene (Nibu et Comparison of genotypic frequencies of single poly-
al. 1994a, 1994a). A systematic search was performed, morphisms were performed by use of contingency x2
by SSCP analysis, on the region containing an enhancer tests. Pairwise linkage-disequilibrium coefﬁcients were
core element from /2170 to /2230, using the primers estimated by the maximum-likelihood method, and the
indicated in table 1 and three different nondenaturing extent of disequilibrium was expressed as the D Å D/
conditions. This systematic search was done in 20 Dmax or D/Dmin, according to Thompson et al. (1988).
M235M homozygous and 20 T235T homozygous Allelic or haplotypic frequencies for one or more loci
French individuals. No electrophoretic variant was ob- were estimated by the maximum-likelihood method, by
served. In addition, direct sequencing also was per- use of a simpliﬁed version of the computer program
formed in 16 individuals, all homozygous for the T235 GENEF (J.-M. Lalouel, unpublished data). In analyses
involving single codominant loci, this coincides with di-allele, for the 5 region of the gene (from nucleotide
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Table 1
Primers Used for Detection of Mutations in 5 Region of AGT Gene by SSCP Analysis
Location Forward Primer Reverse Primer
01221 to 01004 AGACAAGTGATTTTTGAGGAGTC AACAACAAAGAGCAGGAAGAGATGG
01049 to 0797 CTTCTGCCTCATATCCAGGC ACCTTGGTGAGAGTCGCCAG
0867 to 0 656 ATCACCACTCCCAACCTGCC ATGCCTTCAGGATGCAGGCA
0706 to 0456 ACATTTGCAATTTGTACAGC GCCCGCTCATGGGATGTG
0421 to 0171 AAGACTCTCTCCCCTGCCCTC GAAGTCTTAGTGATCGATGCAG
0164 to /73 AGAGGTCCCAGCGTGAGTGT AGACCAGAAGGAGCTGAGGG
/2141 to /2258 ACAGATGTATACAATTCAGCAG CACCTAAAACTTCAAAGGACTG
rect gene counting. Rather than estimating frequencies and 01074 (ﬁg. 1). None occurs in a region known,
so far, to affect the expression of the AGT gene. Noof a large number of unobserved haplotypes, however,
we used a sequential inclusion procedure operating as electrophoretic variant was found either in the 80 bp of
exon 5 (/1399 to /1478) by SSCP analysis or in thefollows: (1) after inclusion of the M235T polymor-
phism, additional polymorphisms were sequentially entire untranslated 3 region by direct sequencing of 16
subjects homozygous for TT235.added one at a time; joint estimation of haplotypes
yielded the minimum sets of haplotypes required to ac- The frequencies of seven polymorphisms located
within 1 kb of the 5 region of the gene, the M235Tcount for the observations, with all haplotypes below a
frequency of 1/4N, where N is the sample size, being and T174M variants in exon 2, and one polymorphism
in intron 3 were analyzed in hypertensive and normoten-automatically eliminated; (2) in ﬁve instances, a rare
haplotype was required to account for only one possible sive subjects (table 3). The signiﬁcantly higher fre-
quency, in Japan, of T235 in hypertensive subjects com-observed genotype, and a parsimonious solution was
obtained by deleting that rare genotype. The ﬁnal set of pared with normotensive controls has been reported
elsewhere (Hata et al. 1994). The study of French sub-haplotypes generated remained the same, whatever the
jects conﬁrmed the previously reported association (Jeu-order in which markers sequentially were added, and
nemaitre et al. 1992) in another set of cases and controlsonly ﬁve genotypes required unique, rare haplotypes and
(.47 vs. .38, respectively; P Å .004). However, the fre-consequently were excluded.
quency of the T174M variant was not signiﬁcantly dif-Since most of the polymorphisms were in complete
ferent between hypertensives and controls, whetherlinkage disequilibrium with one another, this strategy
from France or from Japan. A signiﬁcant increase of theled to nearly unambiguous haplotypes. Thus, instead of
G-6A variant was observed in both groups, parallelinga global maximum-likelihood method that would have
the difference observed for M235T. One other polymor-raised more df, statistical comparisons between cases
phism, C-776T, displayed a signiﬁcant difference be-and controls were performed by use of simple x2 tests
tween French hypertensives and controls (.08 vs. .03, Pof homogeneity, with continuity correction.
Å .001), but that association was not replicated in the
Results Japanese groups.
Diallelic Polymorphisms Pairwise Linkage Disequilibrium
Since our previous report, four additional variants The polymorphisms were typed in the entire set of
Utah CEPH grandparents, in addition to the groupshave been detected, at positions 0776, 0793, 0830,
Table 2
Primers Used for Detection of ATG Polymorphisms by Speciﬁc Oligonucleotide Hybridization
Location Primer 1 Primer 2
020 ATAGGGCATCGTGAC ATAGGGCCTCGTGAC
0532 GTGTGTTTTCCCCAGT TGTGTGTTTTTCCCAGT
0776 TGTTATAACGACTACAA TGTAGTCATTATAACAG
0793 AGGGCATGACAGAGAC GTCTCTATCATGCCCT
0830 GTCACTTGTGATCACTG GTCACTTGAGATCACTG
01074 TGTTTGTTGATTGTTCA TGAACAATAAACAAACA
Int3 ATCTCCCCAGGACCATC GATGGTCCTTGGGAGAT
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Figure 1 Schematic diagram of the human angiotensinogen gene and location of identiﬁed variants. The positions of the variants in the
5 region are numbered by reference to the transcription-initiation site as deﬁned by Gaillard et al. (1989). The two polymorphisms of exon
2 are at amino acid residues 174 and 235. The intron 3 polymorphism is located at position 013 upstream of the beginning of exon 4.
described above, and their patterns of linkage disequi- morphisms exhibited a quasi-complete linkage disequi-
librium with M235T, each variant being only a subsetlibrium were examined. Most of the polymorphisms
were in complete linkage disequilibrium with one an- of the T235 alleles. It is important to note that, in both
populations, the G-6A polymorphism was in completeother (table 4). The patterns of linkage disequilibrium
analyzed in the CEPH group were in close agreement linkage disequilibrium with M235T and occurred with
the same frequency. Thus, the two polymorphisms al-with those observed in French Caucasians. Despite
strong ethnic differences in the frequency of the T235 most always were seen together. As a result, although
our subsequent analyses will refer primarily toallele, similar patterns of disequilibrium also were ob-
served in the 122 normotensive Japanese (data not M235T, all associations pertaining to the T235 allele
extend directly to the A-6 polymorphism.shown).
In order to subdivide the T235 allele into frequent
Multisite Haplotypeshaplotypes, the linkage-disequilibrium patterns were
summarized in terms of the allelic associations with The distribution of the T235-associated polymor-
phisms into multisite haplotypes was examined ﬁrst ineither T235 or M235 (table 5). The variants A-830
occurred only in genes carrying 235M. All other poly- the CEPH sample. For the purpose of the present
Table 3
Frequency of Angiotensinogen Polymorphisms in Hypertensives and Controls
CAUCASIANS JAPANESE
Frequency Frequency
Hypertensives Controls Hypertensives Controls
POLYMORPHISM (n Å 477) (n Å 364) x22a (n Å 92) (n Å 122) x22a
M235T .465 .379 12.1 (P Å .004) .913 .762 17.4 (P Å .002)
G-1074T .124 .091 4.8 (Not signiﬁcant) Not tested .147
T-830A .067 .060 .8 (Not signiﬁcant) Not tested Not tested
G-793A .127 .092 8.6 (P Å .01) .179 .153 3.8 (Not signiﬁcant)
C-776T .080 .034 18.8 (P Å .001) .092 .108 2.3 (Not signiﬁcant)
C-532T .122 .094 4.7 (Not signiﬁcant) Not tested Not tested
A-20C .160 .175 1.0 (Not signiﬁcant) .225 .195 .7 (Not signiﬁcant)
G-6A .466 .384 11.0 (P õ .01) .900 .742 19.1 (P õ .001)
T174M .114 .117 1.0 (Not signiﬁcant) .117 .076 2.3 (Not signiﬁcant)
A-13G(int3) .082 .069 1.8 (Not signiﬁcant) .376 .287 5.0 (Not signiﬁcant)
a Test on genotype frequencies.
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Table 4
Pairwise Linkage-Disequilibrium Coefﬁcients, between AGT Gene Polymorphisms, Estimated in Caucasian Controls
{D a
POLYMORPHISM M235T G-1074T T-830A G-793A C-776T C-532T A-20C G-6A T174M
G-1074T 1.00 . . . . . . . . . . . . . . . . . . . . . . . .
T-830A 01.00 0.75 . . . . . . . . . . . . . . . . . . . . .
G-793A 1.00 1.00 0.51 . . . . . . . . . . . . . . . . . .
C-776T 1.00 .77 1.00 .77 . . . . . . . . . . . . . . .
C-532T 1.00 .96 0.63 .97 1.00 . . . . . . . . . . . .
A-20C 1.00 01.00 01.00 01.00 .57 01.00 . . . . . . . . .
G-6A .97 1.00 0.76 1.00 01.00 1.00 1.00 . . . . . .
T174M 1.00 01.00 01.00 1.00 .40 01.00 .94 1.00 . . .
A-13G(int3) .97 01.00 .00 1.00 .98 01.00 01.00 .92 01.00
a All coefﬁcients with absolute values ú.70 signiﬁcantly differ from 0 (P õ 1004).
study—that is, testing of the homogeneity of T235 hap- cal decrease of the T235 allele, a decrease already
observed in the single-locus analysis. In Caucasians, thelotypes with respect to risk of hypertension—we sought
to conserve df by generating a parsimonious set of hap- difference in H1 frequency (.093, P õ .001) was ex-
plained mainly by two haplotypes: H3 (T235/T-776)lotypes involving as many site polymorphisms as could
be achieved. Although there is no formal, optimal solu- and H4 (T235/A-793). This pattern was not observed
in Japanese, where most of the haplotypes subdividingtion to this problem, the observed patterns of multiway
linkage disequilibrium yielded a rather straightforward T235 displayed a small difference between hypertensives
and controls. In this group, the only marginal signiﬁcantsolution. Variants at sites 01074, 0793, and 0532,
with a few exceptions, always occurred together; only difference was observed for the T235 haplotype not
bearing any other polymorphism (i.e., H2; see table 7).site 0793 was considered in further analyses.
Sequential addition of site polymorphisms, indepen-
Distribution of the GT Allelesdently of the sequence used for their incorporation, led
In order to investigate the possibility of an associationinvariably to a parsimonious set of ﬁve common haplo-
between a multiallelic series of alleles at this locus andtypes of T235, deﬁned by ﬁve site polymorphisms (table
hypertension, alleles of the microsatellite dinucleotide6). In the CEPH sample, these ﬁve sites account for 233
(GT) repeat at the angiotensinogen locus (Kotelevstev etof 238 haplotypes tested at all sites. Only ﬁve genotypes
al. 1991) were examined in all samples. The frequenciesrequired unique, rare haplotypes and, consequently,
observed in Utah CEPH subjects were very similar towere excluded. Inclusion of the A-13G(Int3) polymor-
those exhibited by French controls (data not shown).phism would have required retention of multiple rare
To reduce df, alleles at either end of the distributionhaplotypes or deletion of multiple T235 genes. To con-
were pooled. A signiﬁcant difference was observed be-serve power and df, this polymorphism was not included
tween normotensive and hypertensive Caucasian sub-in subsequent analyses. The ﬁnal set of haplotypes gener-
jects (x2 [7 df]Å 21.56, P õ .01). The decrease in (GT)16ated remained the same, whatever the order in which
in hypertensives compared with normotensives (.358 vs.markers were added sequentially. Because of the very
.416) accounted for most of this statistical differencesimilar linkage disequilibrium, in both populations, be-
(ﬁg. 2). As a consequence, a slight increase was detectedtween M235T and the other diallelic polymorphisms,
in the other alleles, but no particular shift from one tothe same haplotypes were generated in both the Cauca-
another could be observed.sian group and the Japanese group.
A different pattern was observed in the Japanese.
Testing Haplotypes in Hypertensives and Compared with that observed in Caucasians, the distri-
Normotensives bution was shifted toward shorter and longer alleles, the
(GT)16 allele accounting only for 11.4% and 8.9% of theThe estimated frequencies of the six haplotypes identi-
ﬁed above were compared, between hypertensive and alleles in controls and hypertensives, respectively (ﬁg. 2).
When all the alleles were analyzed, a marginally signiﬁ-controls, in both the French Caucasian population and
the Japanese population (table 7). The strong and sig- cant difference was observed between normotensive and
hypertensive Japanese (x2 [7 df] Å 14.1, P õ .05). Aniﬁcant increase of H1 in normotensives that was ob-
served in both populations simply reﬂects the symmetri- tendency toward longer alleles was observed in hyper-
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Table 5 French and Japanese groups (ﬁgs. 3 and 4). Each individ-
ual variant showed a strong degree of association with
Association between Each Diallelic Angiotensinogen Polymorphism
GT alleles that was very similar in both populationsand T235 Allele
and in hypertensive and normotensive subjects (data not
Polymorphism and Sample (n) Pia Pijb Pj/ic shown). The highest associations were observed for
M174, exhibiting 91% and 95% of (GT)14 in French
M235T: and Japanese, respectively, and for G(Int3), exhibiting
CEPH grandparents (152) .388 . . . . . .
88% and 84% of (GT)ú20 in French and Japanese, re-French controls (364) .380 . . . . . .
spectively. Only the T(0776) variant showed a differentJapanese controls (122) .762
G-1074T: pattern of linkage disequilibrium, mainly associated
CEPH grandparents (148) .098 .098 1.00 with (GT)17 in French and with (GT)£13 in Japanese.
French controls (360) .091 .090 .99 Since there was a signiﬁcant association between
Japanese controls (122) .153 .153 1.00
T235 and hypertension, it was important to examineT-830A:
the conditional distributions of GT alleles within hap-CEPH grandparents (139) .090 .000 .00
French controls (344) .060 .000 .00 lotypes carrying either M235 or T235. Whereas the
Japanese controls (. . .) . . . . . . . . . distribution of the GT alleles for T235 was almost
G-793A: uniform, 65% of M235 genes exhibited allele (GT)16CEPH grandparents (138) .098 .081 .83
in CEPH individuals and French controls, as a conse-French controls (343) .092 .092 1.00
quence of the strong linkage disequilibrium betweenJapanese controls (122) .147 .143 .97
C-776T: these two polymorphisms. In Japanese individuals,
CEPH grandparents (137) .048 .037 .76 38%, 21%, and 19% of M235 genes exhibited the
French controls (338) .034 .034 1.00 (GT)16, (GT)17, and (GT)13–14 alleles, respectively.Japanese controls (114) .110 .110 1.00
These patterns of linkage disequilibrium also were ob-C-532T:
served in hypertensive individuals (data not shown).CEPH grandparents (142) .106 .106 1.00
French controls (277) .094 .091 .97
The 235T/A-6 Allele—Ancestral Form of the AGTJapanese controls (. . .) . . . . . . . . .
A-20C: Genes
CEPH grandparents (144) .135 .135 1.00 The associations between the different polymor-
French controls (339) .177 .177 1.00
phisms of the human AGT gene are summarized in ﬁgureJapanese controls (108) .185 .185 1.00
5. The broad, uniform distribution of GT alleles, asG-6A:
CEPH grandparents (145) .369 .362 .98 well as the presence of multiple site polymorphisms on
French controls (364) .386 .376 .97 haplotypes carrying both T235 and A-6, suggest that
Japanese controls (113) .743 .739 .99 T235 and A-6 may mark the original form of the gene.
T174M:
This interpretation is supported further by the presenceCEPH grandparents (138) .101 .101 1.00
of this form of the gene in all primate species examinedFrench controls (355) .117 .117 1.00
Japanese controls (122) .078 .078 1.00 (Inoue et al. 1997).
A-13G(int3): The patterns of association exhibited by a number of
CEPH grandparents (146) .079 .079 1.00 diallelic polymorphisms suggest that molecular variants
French controls (362) .069 .067 .97
Japanese controls (120) .296 .296 1.00
a Frequency of variant i. Table 6
b Joint frequency of variant i and T235.
c Conditional probability that a gene carries T235, given that it Angiotensinogen Haplotypes
carries i.
STATUS OF ALLELEb
HAPLOTYPEa T235 M174 T-776 A-793 C-20
tensives, signiﬁcant when the overall distribution was
H1 0 0 0 0 0partitioned into two groups, one group more than and
H2 / 0 0 0 0
the other group equal to or less than the (GT)17 H3 / 0 / 0 0
(x2[1 df] Å 8.76, P Å .004). H4 / 0 0 / 0
H5 / 0 0 0 /
H6 / / 0 0 /Conditional Distributions of the GT Alleles, According
to Diallelic Polymorphisms a Only informative haplotypes have been mentioned.
Conditional distributions of the GT alleles, given b A plus sign (/) denotes presence of allele; and a minus sign (0)
denotes absence of allele.other diallelic polymorphisms, were analyzed in the
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Table 7
Haplotype Frequencies in Hypertensives and Controls
CAUCASIANS JAPANESE
Frequency Frequency
Hypertensives Controls Hypertensives Controls
HAPLOTYPE (n Å 914) (n Å 644) x21 (n Å 176) (n Å 198) x21
H1: M235 .540 .633 13.88 (P õ .001) .091 .242 15.08 (P õ .001)
H2: T235 .101 .079 2.32 .426 .328 3.81 (P õ .05)
H3: T235/T-776 .073 .031 12.78 (P õ .001) .074 .101 .85
H4: T235/A-793 .124 .085 6.03 (P õ .01) .182 .146 .85
H5: T235/C-20 .048 .053 .16 .131 .101 .81
H6: T235/M174/C-20 .109 .118 .77 .097 .081 .29
have arisen by mutation on ancestral genes carrying carefully selected normotensive subjects without family
history of hypertension. The increased frequency ofT235 and a particular GT allele. This pattern of genetic
diversity suggests a development by spatial divergence T235 in hypertensives (.47 vs. .38, P õ .001) was com-
parable to that previously observed in the series of 217in subdivided populations, rather than by temporal di-
vergence in a homogeneous founder population. It is cases and 232 controls coming from Utah and Paris
(Jeunemaitre et al. 1992). Since some cases-control stud-intriguing that the M235 variant, which occurs mainly
on (GT)16, is strongly associated also with the G-6 sub- ies provided no support for the association between
T235 and hypertension, it probably is crucial here tostitution. The persistence of this association may have
arisen by chance, or it may represent a coordinated re- emphazise the importance of sample size when one
wants to test such association in a complex disease suchsponse to natural selection.
as hypertension. Indeed, a common feature of these neg-
ative studies is their small sample size and/or the uncer-Discussion
tain or unusual ascertainment of either cases or controls
(Bennett et al. 1993; Barley et al. 1994; Caulﬁeld etThe AGT gene constitutes, so far, the only locus that
al. 1994; Fornage et al. 1995). To replicate the initialconsistently has been linked to essential hypertension in
difference (Jeunemaitre et al. 1992), of allele frequencies,humans (Jeunemaitre et al. 1992; Caulﬁeld et al. 1994,
between hypertensive and normotensive Caucasians (.471995). The fact that this linkage was established in hy-
vs. .36) with an 80% power, §400 cases and §400pertensive sibling pairs and families not selected for any
controls would be required, if a codominant effect ofintermediate phenotype other than BP itself indicates
the T235 allele is assumed, thereby conﬁrming that smallthat the AGT locus must be implicated in the pathogene-
samples lack the statistical power required to detectsis of the disease in a substantial proportion of these
small statistical differences. In the Japanese, the reducedfamilies. Given the high prevalence of hypertension, pre-
heterogeneity of the pathophysiology of hypertensiondisposing mutations in the AGT gene should be present
could be due to a more homogeneous genetic and envi-at a rather high frequency in the population. Association
ronmental background of the population (Hata et al.with the common marker M235T suggests that one pre-
1994; Kamitani et al. 1994; Iwai et al. 1995; Nishiumadisposing mutation accounts for a large proportion of
et al. 1995).the risk mediated by AGT. This hypothesis is reinforced
Generation of haplotypes is a powerful method forby the association of M235T with increased plasma an-
testing the hypothesis that a speciﬁc allele mediates pre-giotensinogen levels (Jeunemaitre et al. 1992, 1993;
disposition, and it explains the observed association ofBloem et al. 1995) and by the importance of renin-sub-
the T235 allele with hypertension. Two types of geneticstrate concentration to both plasma renin activity
polymorphism can be applied to generate haplotypes:(Gould and Green 1971) and BP homeostasis (Gardes
(1) diallelic polymorphisms resulting from point muta-et al. 1982; Kim et al. 1995).
tions and (2) multiallelic variation associated with aThis study provides further statistical evidence for the
variable number of simple-sequence tandem repeats.association between the T235 allele and essential hyper-
Several arguments can be proposed in support of thetension in Caucasians. This result was obtained on both
use of a battery of diallelic series to partition T235 hap-a large number (n Å 477) of hypertensive probands of
hypertensive families and a large number (n Å 364) of lotypes. First, there is ample evidence that, on an evolu-
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cans, Japanese, and Indian Americans), compared with
only one group (northern Europeans) in which the
M235 allele is more frequent (Jeunemaitre et al. 1992;
Hata et al. 1994; Rotimi et al. 1994; Iwai et al. 1995;
Schmidt et al. 1995); and (3) the homozygosity, for
T235, in 20 chimpanzees (personal results) and all pri-
mate monkeys (gorilla, orangutan, gibbon, macaque,
and baboon) analyzed by Inoue et al. (1997). Thus, an
accumulation of nucleotide substitutions would be more
likely to happen in the T235 allele, with its longer evolu-
tionary time span. Consequently, the primary emphasis
of our inquiry was haplotypes of T235 that are derived
from diallelic series.
We extensively tried to address this question by identi-
fying new polymorphisms at the AGT locus. A total of
10 diallelic polymorphisms were genotyped in a large
series of hypertensives and controls originating from
two separate ethnic origins. The linkage disequilibrium
observed between these polymorphisms was very similar
in both Caucasians and Japanese and led invariably to
a parsimonious set of ﬁve common haplotypes of T235.
No special haplotype consistently accounted for this as-
sociation in both groups. However, the frequencies of
the two haplotypes bearing the 0776 and 0793 poly-
morphisms were found to be statistically different be-
tween hypertensive and normotensive Caucasians. These
two particular haplotypes could be in linkage disequilib-
rium with some mutations, present mainly in Cauca-
sians, that would affect either the expression or the func-
tion of angiotensinogen.
Figure 2 Distribution of AGT microsatellite alleles in French Different arguments make this hypothesis unlikely.
(top) and Japanese (bottom) hypertensives and normotensives. Alleles
First, although not all mutations led to detectable con-are numbered a1–a11, according to the classiﬁcation adopted by Ko-
formation polymorphisms, only three rare mutations intelevtsev et al. (1991) as well as by direct reference to the number of
GT repeats in each allele. A signiﬁcant difference was observed be- the coding sequence—one at the cleavage site for renin
tween French normotensive and hypertensive subjects (x2 [7 df] (Inoue et al. 1995) and two others, at the 209 and 211Å 21.56, P õ .01), mainly because of the decrease in (GT)16 in hyper- residues and each detected in one African Carribean
tensives compared with controls (.358 vs. .416). A marginally signiﬁ-
family (Hixson and Powers 1995)—have been reported,cant difference was observed between normotensive and hypertensive
so far, in the literature, in comparison with our initialJapanese (x2 [7 df] Å 14.1, P õ .05), explained mainly by a tendency
toward longer alleles, (GT)§17, in hypertensives. study (Jeunemaitre et al. 1992). Second, we could not
identify any additional mutation when all exons, splice
junctions, and the 3 UTR of the gene were sequenced
in 16 individuals homozygous for the T235 allele. Third,tionary time scale, single nucleotide substitutions are
much more stable than are simple-tandem-repeat se- substitutions at the 0776 and 0793 sites are not part
of a theoretical consensus sequence that could play aquences (Stallings et al. 1991). For a common risk fac-
tor, a multiallelic series may dissipate statistical power, role in angiotensinogen expression, although the case of
this latter variant is more complex, since it is combinedthrough both the generation of a large number of df and
the functional mutation into a number of marker alleles with two other substitutions (01074 and 0532). Little
is known, however, about the transcriptional factors(Hyer et al. 1991). Second, several arguments support
the hypothesis that the T235 allele marks the original that bind to the AGT promoter, and the possibility that
AGT expression may vary either because of these vari-form of the gene and that M235 is the neomorph: (1)
the strong linkage disequilibrium between M235 and ants or because of other mutation(s) located farther up-
stream of the AGT gene cannot be ruled out. Finally, inone of the alleles of the AGTmicrosatellite marker, com-
pared with the quasi-uniform distribution of the GT- the case of a true association, one would have to postu-
late that the haplotypes H3 (0776 and 235T) and H4repeat alleles among T235 genes; (2) the higher fre-
quency of the T235 allele in three ethnic groups (Afri- (0793C and 235T) do constitute different alleles predis-
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Figure 3 Conditional distributions of the AGT microsatellite alleles, according to each diallelic polymorphism in French Caucasians. For
each of the diallelic polymorphisms, the conditional probability of each of the alleles of the AGT microsatellite is represented. For example, a
strong linkage disequilibrium was observed, in both French and Japanese populations, between M174 and (GT)14.
Figure 4 Conditional distributions of the AGT microsatellite alleles, according to each diallelic polymorphism in Japanese
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a limited number of African Carribean normotensive
and hypertensive subjects, would lead to the same com-
plex genetic hypothesis.
One signiﬁcant outcome of our search for a causative
mutation at the AGT locus was the ﬁnding that a poly-
morphism occurring six residues upstream from the ini-
tiation site of transcription was in very strong linkage
disequilibrium with the polymorphism at residue 235.
The frequencies of the A-6 and the T235 alleles are
Figure 5 Diversity of the different alleles originating from a almost identical, with ú97% concordance between thecommon ancestral haplotype (T235/A-6). Each of the diallelic poly-
two substitutions, in both the French and the Japanesemorphisms originates on a common ancestral haplotype (T235/A-6),
groups. As a consequence, all statistical associations ob-accompanied by a speciﬁc (GT) repeat allele, suggesting an evolution
in space rather than in time. TheM235 is one of those polymorphisms, served—and interpretations proposed—for T235 di-
speciﬁcally associated with the G-6 substitution in the promoter rectly extend to A-6. Although the MetrThr substitu-
region. tion at position 235 alters the immunological
recognition of the protein (Cohen et al. 1996), expres-
sion studies do not demonstrate any difference, in glyco-
sylation, secretion, or enzymatic properties, between theposing to human hypertension in Caucasians but not in
Japanese. Since the T235 allele was increased to the two recombinant angiotensinogens (Inoue et al. 1997).
By contrast, the region encompassed by positions 025same extent in both populations, it would imply an un-
likely genetic or environmental interaction speciﬁc to and 01 of the human AGT gene represents a transcrip-
tionnally important cis-acting sequence (Yanai et al.these haplotypes and to Caucasians.
Two reports have suggested the existence of speciﬁc 1996). However, the role of this region in AGT tran-
scription could be complex, since different nuclear fac-alleles of the AGT gene that predispose to high BP. In
their ﬁrst study, involving 63 Caucasian families re- tors seem to bind at the 5 versus 3 parts of this cis-
acting element (Yanai et al. 1996; Inoue et al. 1997).cruited in London, Caulﬁeld et al. (1994) reported a
surprisingly strong association between alleles of the Interestingly, in vitro experiments demonstrate that the
GrA substitution at position 06 affects the basal tran-AGT-GT repeat and essential hypertension. In particu-
lar, the most common allele in the reference population, scription rate of the AGT gene (Inoue et al. 1997). Thus,
this substitution actually could represent the causativea7 or (GT)16, occurred at much lower frequency in the
63 hypertensive probands than in the 80 controls (.07 vs. mutation explaining the association between T235 and
both increased plasma angiotensinogen and, conse-.31), whereas allele a6 or (GT)17, exhibited the opposite
trend (.36 vs. .17). These results would lead to the hy- quently, hypertension.
Until the development of genetically selected strainspothesis that two factors, one protective and the other
predisposing, occur in disequilibrium with two succes- of animals, humans appeared to be a unique species in
their apparent predisposition to hypertension, sug-sive alleles of the GT repeat. There are several arguments
against such a complex genetic hypothesis: (1) it is not gesting a speciﬁc interaction between genetic factors and
the variation of human environment (McCarron et al.supported either by our initial study (Jeunemaitre et al.
1992) or by the present study, each of which was per- 1983). On the basis of our data, it is tempting to specu-
late about the role of different angiotensinogen allelesformed on a much larger (greater than ﬁvefold) number
of control and hypertensive subjects; (2) the only differ- in this interaction. Through the phylogenetic history of
the vertebrates, it has become clear that the renin angio-ence in frequency of the GT alleles, observed in both
Utah and Paris subjects, was a decrease in the most tensin system has played a key role in the adaptation of
living creatures to their salt environment, from marinecommon allele, a7 or (GT)16, in hypertensives compared
with normotensives (.34 vs. .41); (3) this difference is to freshwater milieu, from aquatic to terrestrial life,
maintaining BP and sodium balance through vasocon-predicted by the linkage disequilibrium between M235
and (GT)16 (P[M235/(GT)16] Å .92) in those popula- striction and salt retention (Henderson and Deacon
1993). It is very likely that, several million years ago,tions; and (4) the linkage disequilibrium between M235
and (GT)16 also occurs in Japanese subjects (P[M235/ the diet of hominoids was almost exclusively vegetarian
(Eaton and Conner 1985), thus containing a very low(GT)16] Å .81). The results obtained from Caulﬁeld et
al. (1994) therefore are inconsistent with the absence level of sodium and a high potassium intake, which can
constitute a strong selective environment. That selectionof a difference, in M235 frequency, between cases and
controls in that particular study. The second study pressure could have favored salt-retention mechanisms
already developed at earlier stages of phylogeny, re-(Caulﬁeld et al. 1995), which found marked differences
in allele a8 and a9 frequency of the AGT-GT repeat in sulting in the selection of alleles resulting in an optimal
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tensinogen gene locus to human essential hypertension insalt reabsorption (Denton 1984). This environmental
African Caribbeans. J Clin Invest 96:687–692stressor could have been even stronger for the ﬁrst ances-
Charru, A, Jeunemaitre X, Soubrier F, Corvol P, Chatellier Gtors of human species, because of the change to the
(1994) HYPERGENE: a clinical and genetic database forenvironment (from forest to savana) and to the required
genetic analysis in human hypertension. J Hypertens 12:adaptation to upright posture. The angiotensinogen al-
981–985lele would be one of these genes leading to increased
Cohen P, Badouaille G, Gimenez-Roqueplo AP, Guyene TT,
sodium reabsorption and increased BP. In this respect, Jeunemaitre X, Me´nard J, Corvol P, et al (1996) Selective
it is interesting to note that the T235T/A-6 allele is found recognition of M235T angiotensinogen variants and their
in chimpanzees, in which an increased salt intake causes determination in human plasma by monoclonal antibody-
a large rise in BP (Denton et al. 1995). More recently, based immunoanalysis. J Clin Endocrinol Metab 81:3505–
increased availability and use of salt may have allowed 3512
genetic variants with a lesser effect on sodium retention Denton D (1984) Hominoid evolution and their inﬂuences on
sodium homeostasis. In: The hunger for salt: aA anthropo-and on BP to accumulate, resulting in the development
logical, physiological and medical analysis. Springer, Newof salt resistance. Nowadays, the analysis of different
York, pp 53–75living human groups shows not only different frequen-
Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A,cies of the T235 allele, according to their diversity and
Moisson P, Pingard AM, et al (1995) The effect of increasedhistory, but also the residual effect of this gene on BP
salt intake on blood pressure of chimpanzees. Nat Med 1:in a modiﬁed environment.
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